| 000 | 01743 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250511174849.0 | ||
| 264 | 0 | _c19930128 | |
| 008 | 199301s 0 0 eng d | ||
| 022 | _a0007-1188 | ||
| 024 | 7 |
_a10.1111/j.1476-5381.1992.tb13398.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZembowicz, A | |
| 245 | 0 | 0 |
_aPotentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cDec 1992 |
||
| 300 |
_a1001-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmino Acid Oxidoreductases _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAorta |
| 650 | 0 | 4 |
_aArginine _xanalogs & derivatives |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
| 650 | 0 | 4 |
_aEpoprostenol _xbiosynthesis |
| 650 | 0 | 4 |
_aGuanidines _xpharmacology |
| 650 | 0 | 4 | _aHydroxylamines |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMuscle Relaxation _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 | _aNG-Nitroarginine Methyl Ester |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 | _aNitric Oxide Synthase |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 700 | 1 | _aSwierkosz, T A | |
| 700 | 1 | _aSouthan, G J | |
| 700 | 1 | _aHecker, M | |
| 700 | 1 | _aVane, J R | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 107 _gno. 4 _gp. 1001-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1476-5381.1992.tb13398.x _zAvailable from publisher's website |
| 999 |
_c1288247 _d1288247 |
||